|
Approve Suite Weekly · Tuesday, November 3, 2026 · read online
Class I: Philips Ultrasound, LLC — Philips Lumify Diagnostic…
Philips Lumify ultrasound system Class I recall for transducer registration and connection failures. This Class I recall affects a portable diagnostic device with safety-critical functional failures including loss of transducer recognition and unstable USB connections that may prevent scanning and delay clinical diagnosis or treatment decisions. Travere reports Q3 2026 FILSPARI sales of $200M with 120% YoY growth; Phase 3 and IND programs on track. This earnings announcement discloses commercial performance of an approved product (FILSPARI) and updates on ongoing clinical development programs. The information signals product market traction and pipeline progression relevant to stakeholders tracking the company's regulatory and commercial trajectory. The pattern? Recalls led the week with 195, ahead of 8-K filings (28), out of 242 counted.
This week's author: Ryan Burke, Approve Suite
Class I: Philips Ultrasound, LLC — Philips Lumify Diagnostic Ultrasound System
Class I · Philips Ultrasound, LLC
Philips Lumify ultrasound system Class I recall for transducer registration and connection failures.
Why it matters. This Class I recall affects a portable diagnostic device with safety-critical functional failures including loss of transducer recognition and unstable USB connections that may prevent scanning and delay clinical diagnosis or treatment decisions.
What to watch. The classification and, later, the termination notice both post to openFDA; Class I recalls also appear as safety alerts.
READ MORE → · open in Approve Suite
|
Presented by Approve Suite
Put a watchlist on this. Name your CDMO and competitors; get these the day they post. $79/mo, no card to start. See pricing →
|
8-K: Travere Therapeutics, Inc. mentions topline results
8-K · Travere Therapeutics, Inc.
Travere reports Q3 2026 FILSPARI sales of $200M with 120% YoY growth; Phase 3 and IND programs on track.
Why it matters. This earnings announcement discloses commercial performance of an approved product (FILSPARI) and updates on ongoing clinical development programs. The information signals product market traction and pipeline progression relevant to stakeholders tracking the company's regulatory and commercial trajectory.
What to watch. Items 1.01, 2.02 and 8.01 carry the material terms; the exhibits hold the detail.
READ MORE → · open in Approve Suite
|
Presented by Approve Suite
Put a watchlist on this. Name your CDMO and competitors; get these the day they post. $79/mo, no card to start. See pricing →
|
Safety communication: FDA Advises Consumers Not to Buy or Serve Once Upon a Farm Tractor Wheels Organic Toddler Soft-Baked Bars
Once Upon a Farm
FDA warns against Once Upon a Farm Tractor Wheels toddler bars due to choking hazard.
Why it matters. This safety communication signals a potentially fatal hazard in a consumer product marketed to toddlers. Regulatory action reflects serious choking risk requiring immediate consumer notification and market withdrawal.
What to watch. Open the source; what comes next depends on the agency's follow-up.
READ MORE → · open in Approve Suite
By the numbers
Inspections: 0 NAI · 0 VAI · 0 OAI Warning letters: 0 Class I recalls: 25 (Class II 139, Class III 31) Trial stops and status changes: 11 (results posted: 4) Raises: 8, $88M disclosed
338 events, down 53% on the prior 7 days.
200 listed companies report under 12 months of runway.
Signals
1. Class I: Ventec Life Systems, Inc. — VCSN+Pro Model Number: PRT-01184-000, Package PN:PRT-01172-000. used for ventilatory support. Class I · Ventec Life Systems, Inc. app 2. Class I: Ventec Life Systems, Inc. — VOCSN+Pro, Model Number:PRT-00490-001, Package PN:PRT-00853-000. used for ventilatory support. Class I · Ventec Life Systems, Inc. app 3. 8-K: Seaport Therapeutics, Inc. mentions topline results 8-K · Seaport Therapeutics app 4. 8-K: CERUS CORP mentions topline results 8-K · Cerus Corporation app 5. NCT06889207: Physical Exercise Prehabilitation Program in mEtabolic suRgery — Now TERMINATED Flevoziekenhuis app 6. Medical Devices; Radiology Devices; Classification of the Radiology Software for Referral of Findings Related to Fibrotic Lung Disease Final rule app
Why this exists
Approve Suite Weekly exists so a QA or RA lead can read one email on Tuesday and know what changed in FDA regulation, inspections and trials in the past week. Every line links to its public source.
Sponsor this email
How was this week's email?
AwesomeDecentNot great
|